Patients with a personal or family history of polycythemia, cardiovascular disease, sleep apnea, or liver dysfunction face elevated risks with testosterone
Among the 12mg group, 58.6% achieved 25% or greater weight loss, 39.4% achieved 30% or greater, and 23.7% achieved 35% or greater
Start your intake Clinical Weight Loss Results from Semaglutide Trials The STEP trials, the largest clinical studies of semaglutide for weight loss, tracked over 4,500 adults across 16 weeks of treatment escalation followed by 52 weeks of maintenance dosing
D.KaufmanM
There's no lock-in period, though continuing your current medication dose may ease the transition
& Premasudha Sadananda, M